Clinical Trial Update: Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma

View source ↗

Summary

Clinical trial update describing a long-term follow-up study of late effects after treatment in patients with high-risk neuroblastoma; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Neuroblastoma, Stage 2A Neuroblastoma | Status: ACTIVE_NOT_RECRUITING